HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ro5203280

a polo kinase inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cheung, Arthur Kwok Leung: 1 article (08/2013)
2.	Ip, Joseph Chok Yan: 1 article (08/2013)
3.	Lung, Hong Lok: 1 article (08/2013)
4.	Lung, Maria Li: 1 article (08/2013)
5.	Tsao, Sai Wah: 1 article (08/2013)
6.	Wu, Jim Zhen: 1 article (08/2013)

Related Diseases

1.	Neoplasms (Cancer) 08/01/2013 - "Ro5203280 induces tumor suppression both in vitro and in vivo. " 08/01/2013 - "In vivo tumorigenicity assays with Ro5203280 intravenous injection showed its potent ability to inhibit tumor growth in mice, with no observable signs of toxicity. "
2.	Nasopharyngeal Carcinoma 08/01/2013 - "These findings suggest the potential usefulness of Ro5203280 as a chemotherapeutic targeting drug for nasopharyngeal carcinoma treatment." 08/01/2013 - "Polo-like kinase inhibitor Ro5203280 has potent antitumor activity in nasopharyngeal carcinoma."

Related Drugs and Biologics

1.	Phosphotransferases (Kinase)

Related Therapies and Procedures

1.	Intravenous Injections